TERIPARATIDE Side Effects

7023163-0 | Pelvic Fracture, Subdural Haematoma, Upper Limb Fracture
on Sep 16, 2010 Female patient from UNITED STATES , weighting 101.9 lb, was diagnosed with osteoporosis (What is osteoporosis?), depression (What is depression?), anxiety (What is anxiety?), hyperlipidaemia and was treated with Teriparatide (View Usage). Patient experienced the following unwanted or unexpected effects: pelvic fracture, subdural haematoma, upper limb fracture. Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with BONIVA (View Boniva Review and Boniva Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), CALCIUM (View Calcium Review and Calcium Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ). Patient was hospitalized.

6882860-8 | Confusional State, Hypercalcaemia
Patient was taking Teriparatide (View Usage). Patient had the following side effects: confusional state, hypercalcaemia on Jul 15, 2010 from DENMARK Additional patient health information: Female patient , weighting 110.2 lb, was diagnosed with hypertension and. Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6849570-4 | Chest Discomfort, Pneumonia, Tachycardia
Adverse event was reported on Jul 05, 2010 by a Female patient taking Teriparatide (View Usage) (Dosage: ) was diagnosed with osteoporosis (What is osteoporosis?) and. Location: DENMARK , 68 years of age, After Teriparatide was administered, patient had the following side effects: chest discomfort, pneumonia (What is pneumonia?), tachycardia. Patient was hospitalized.

6843362-8 | Breast Cancer Recurrent
on Jul 02, 2010 Female patient from UNITED STATES , weighting 143.0 lb, was diagnosed with osteoporosis (What is osteoporosis?), prophylaxis, heart rate increased, arthropathy, hypothyroidism and was treated with Teriparatide (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer recurrent. Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (25 Mg, Unk) (View Atenolol Review and Atenolol Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), GLUCOSAMINE (1000 Ug, Unk) (View Glucosamine Review and Glucosamine Label ), LEVOXYL (50 Ug, Unk) (View Levoxyl Review and Levoxyl Label ), FOSAMAX (70 Mg, Unk) (View Fosamax Review and Fosamax Label ), VITAMIN C (1000 Mg, Unk) (View Vitamin C Review and Vitamin C Label ).


6745941-5 | Lung Cancer Metastatic
on May 14, 2010 Female patient from SLOVENIA , 79 years of age, weighting 128.7 lb, was diagnosed with osteoporosis postmenopausal and was treated with Teriparatide (View Usage). Patient had the following side effects: lung cancer metastatic. Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with PLIVIT D3 (View Plivit D3 Review and Plivit D3 Label ), AGLURAB (850 Mg, 2/d) (View Aglurab Review and Aglurab Label ), GLUCOTROL XL (Unk, 2 Tablets Morning) (View Glucotrol Xl Review and Glucotrol Xl Label ), COAXIL (Unk, 2 Times 1 Tablet) (View Coaxil Review and Coaxil Label ), OLICARD (40 Mg, Daily (1/d)) (View Olicard Review and Olicard Label ), ASASANTINE (View Asasantine Review and Asasantine Label ), ZALDIAR (Unk, As Needed) (View Zaldiar Review and Zaldiar Label ). Patient was hospitalized and became disabled.

6730160-9 | Anaemia, Non-cardiac Chest Pain, Pancytopenia, Renal Failure Chronic
Patient was taking Teriparatide (View Usage). After Teriparatide was administered, patient had the following side effects: anaemia, non-cardiac chest pain, pancytopenia, renal failure chronic on May 14, 2010 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Male patient , 79 years of age, weighting 117.9 lb, was diagnosed with back pain (What is back pain?), mineral supplementation and. Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with CALCITRIOL (0.5 Ug, Daily (1/d)) (View Calcitriol Review and Calcitriol Label ), TRAMADOL SANDOZ (200 Mg, Daily (1/d)) (View Tramadol Sandoz Review and Tramadol Sandoz Label ). Patient was hospitalized.

6699149-2 | Anaemia, Non-cardiac Chest Pain, Pancytopenia
Adverse event was reported on Apr 16, 2010 by a Male patient taking Teriparatide (View Usage) (Dosage: 20 Ug, Daily (1/d)) was diagnosed with back pain (What is back pain?), mineral supplementation and. Location: TAIWAN, PROVINCE OF CHINA , 79 years of age, weighting 117.9 lb, Patient experienced the following unwanted or unexpected effects: anaemia, non-cardiac chest pain, pancytopenia. During the same period patient was treated with CALCITRIOL (0.5 Ug, Daily (1/d)) (View Calcitriol Review and Calcitriol Label ), TRAMADOL SANDOZ (200 Mg, Daily (1/d)) (View Tramadol Sandoz Review and Tramadol Sandoz Label ). Patient was hospitalized.

6602869-9 | Chest Discomfort, Pneumonia, Tachycardia
on Feb 11, 2010 Female patient from DENMARK , 68 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Teriparatide (View Usage). Patient had the following side effects: chest discomfort, pneumonia (What is pneumonia?), tachycardia. Teriparatide dosage: . Patient was hospitalized.

6542059-1 | Pneumonia
on Jan 11, 2010 Female patient from DENMARK , 70 years of age, was treated with Teriparatide (View Usage). After Teriparatide was administered, patient had the following side effects: pneumonia (What is pneumonia?). Teriparatide dosage: . Patient was hospitalized.

6526437-2 | Granuloma Annulare
Patient was taking Teriparatide (View Usage). Patient experienced the following unwanted or unexpected effects: granuloma annulare on Dec 23, 2009 from LEBANON Additional patient health information: Female patient , weighting 138.9 lb, was diagnosed with osteoporosis (What is osteoporosis?), diabetes mellitus, hypertension, hyperlipidaemia and. Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with AMARYL (1 Mg, 2/d) (View Amaryl Review and Amaryl Label ), CONCOR (5 Mg, Daily (1/d)) (View Concor Review and Concor Label ), LESCOL (80 Mg, Daily (1/d)) (View Lescol Review and Lescol Label ), OROCAL D(3) (View Orocal D(3) Review and Orocal D(3) Label ), VITAMIN D (50 Iu, Weekly (1/w)) (View Vitamin D Review and Vitamin D Label ), LANZOR (View Lanzor Review and Lanzor Label ).

6512982-2 | Depression
Adverse event was reported on Dec 22, 2009 by a Male patient taking Teriparatide (View Usage) (Dosage: 20 Mcg Every Day Sq) was diagnosed with osteoporosis (What is osteoporosis?) and. Location: UNITED STATES , 64 years of age, weighting 183.0 lb, Patient had the following side effects: depression (What is depression?). Patient was hospitalized.

6504213-4 | Pneumonia
on Dec 03, 2009 Female patient from DENMARK , 70 years of age, was treated with Teriparatide (View Usage). After Teriparatide was administered, patient had the following side effects: pneumonia (What is pneumonia?). Teriparatide dosage: . Patient was hospitalized.

6497667-3 | Hepatic Cirrhosis
on Dec 03, 2009 Female patient from DENMARK , weighting 145.1 lb, was diagnosed with osteoporosis (What is osteoporosis?), ascites, gastric ulcer, depression (What is depression?), oedema peripheral and was treated with Teriparatide (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic cirrhosis. Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with SPIREX (250 Mg, Unk) (View Spirex Review and Spirex Label ), LANSOPRAZOL A (30 Mg, Unk) (View Lansoprazol A Review and Lansoprazol A Label ), CITALOPRAM HYDROBROMIDE (20 Mg, Unk) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), FURIX (120 Mg, Unk) (View Furix Review and Furix Label ). Patient was hospitalized and became disabled.

6474603-7 | Breast Cancer Recurrent
Patient was taking Teriparatide (View Usage). Patient had the following side effects: breast cancer recurrent on May 29, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 143.0 lb, was diagnosed with osteoporosis (What is osteoporosis?), prophylaxis, heart rate increased, arthropathy, hypothyroidism and. Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (25 Mg, Unk) (View Atenolol Review and Atenolol Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), GLUCOSAMINE (1000 Ug, Unk) (View Glucosamine Review and Glucosamine Label ), LEVOXYL (50 Ug, Unk) (View Levoxyl Review and Levoxyl Label ), FOSAMAX (70 Mg, Unk) (View Fosamax Review and Fosamax Label ), ASCORBIC ACID (1000 Mg, Unk) (View Ascorbic Acid Review and Ascorbic Acid Label ).

6474212-X | Granuloma Annulare
Adverse event was reported on Nov 24, 2009 by a Female patient taking Teriparatide (View Usage) (Dosage: 20 Ug, Daily (1/d)) was diagnosed with osteoporosis (What is osteoporosis?), diabetes mellitus, hypertension, hyperlipidaemia and. Location: LEBANON , weighting 138.9 lb, After Teriparatide was administered, patient had the following side effects: granuloma annulare. During the same period patient was treated with AMARYL (1 Mg, 2/d) (View Amaryl Review and Amaryl Label ), CONCOR (5 Mg, Daily (1/d)) (View Concor Review and Concor Label ), LESCOL (80 Mg, Daily (1/d)) (View Lescol Review and Lescol Label ), OROCAL D(3) (View Orocal D(3) Review and Orocal D(3) Label ), VITAMIN D (50 Iu, Weekly (1/w)) (View Vitamin D Review and Vitamin D Label ), LANZOR (View Lanzor Review and Lanzor Label ).

6473574-7 | Atrial Fibrillation, Cardiac Failure Congestive, Chronic Obstructive Pulmonary Disease, Myocardial Infarction
on Feb 25, 2009 Female patient from UNITED STATES , weighting 100.3 lb, was diagnosed with osteoporosis (What is osteoporosis?), rheumatoid arthritis (What is rheumatoid arthritis?), blood calcium, vitamin supplementation and was treated with Teriparatide (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), cardiac failure congestive, chronic obstructive pulmonary disease, myocardial infarction. Teriparatide dosage: 20 Ug, Unk. During the same period patient was treated with ENBREL (View Enbrel Review and Enbrel Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), VICODIN (View Vicodin Review and Vicodin Label ), NAPROSYN (View Naprosyn Review and Naprosyn Label ), CALCIUM (View Calcium Review and Calcium Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

6473212-3 | Oesophageal Candidiasis
on Aug 27, 2008 Female patient from UNITED STATES , weighting 121.0 lb, was diagnosed with osteoporosis (What is osteoporosis?), poor quality sleep, arteritis, hypothyroidism, atrial fibrillation (What is atrial fibrillation?), vitamin supplementation and was treated with Teriparatide (View Usage). Patient had the following side effects: oesophageal candidiasis. Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with TYLENOL /SCH/ (500 Mg, 3/d) (View Tylenol /sch/ Review and Tylenol /sch/ Label ), REQUIP (0.5 Meq, Daily (1/d)) (View Requip Review and Requip Label ), PREDNISONE (20 Mg, Daily (1/d)) (View Prednisone Review and Prednisone Label ), LEVOTHYROXINE SODIUM (0.05 Mg, Daily (1/d)) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), COUMADIN (4 Mg, Unk) (View Coumadin Review and Coumadin Label ), MULTI VITAMIN (Unk, Daily (1/d)) (View Multi-vitamin Review and Multi-vitamin Label ), CALCIUM W/VITAMIN D NOS (500 Mg, Daily (1/d)) (View Calcium W/vitamin D Nos Review and Calcium W/vitamin D Nos Label ). Patient was hospitalized.

6473157-9 | Fall, Sternal Fracture
Patient was taking Teriparatide (View Usage). After Teriparatide was administered, patient had the following side effects: fall (What is fall?), sternal fracture on Nov 04, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 121.0 lb, was diagnosed with osteoporosis (What is osteoporosis?), poor quality sleep, arteritis, hypothyroidism, vitamin supplementation and. Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with REQUIP (0.5 Meq, Daily (1/d)) (View Requip Review and Requip Label ), PREDNISONE (20 Mg, Daily (1/d)) (View Prednisone Review and Prednisone Label ), LEVOTHYROXINE SODIUM (0.05 Mg, Daily (1/d)) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), MULTI VITAMIN (Unk, Daily (1/d)) (View Multi-vitamin Review and Multi-vitamin Label ), METHOTREXATE (2.5 Mg, Weekly (1/w)) (View Methotrexate Review and Methotrexate Label ), LASIX (20 Mg, Daily (1/d)) (View Lasix Review and Lasix Label ), ATENOLOL (25 Mg, Daily (1/d)) (View Atenolol Review and Atenolol Label ), CALCIUM (500 Mg, Daily (1/d)) (View Calcium Review and Calcium Label ). Patient was hospitalized.

6473125-7 | Prostate Cancer
Adverse event was reported on Jul 02, 2008 by a Male patient taking Teriparatide (View Usage) (Dosage: 20 Ug, Daily (1/d)) was diagnosed with osteoporosis (What is osteoporosis?), mineral supplementation, rheumatoid arthritis (What is rheumatoid arthritis?), medical diet, hypertension and. Location: UNITED STATES , weighting 182.0 lb, Patient experienced the following unwanted or unexpected effects: prostate cancer (What is prostate cancer?). During the same period patient was treated with KLOR CON (View Klor-con Review and Klor-con Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ).

6473068-9 | Cerebral Haemorrhage, Deep Vein Thrombosis, Pulmonary Embolism
on Nov 13, 2008 Female patient from DENMARK , weighting 121.3 lb, was diagnosed with osteoporosis (What is osteoporosis?), pain (What is pain?), cystitis, convulsion and was treated with Teriparatide (View Usage). Patient had the following side effects: cerebral haemorrhage, deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?). Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with PAMOL (1 G, Each Evening) (View Pamol Review and Pamol Label ), CEFUROXIME (1500 Mg, 3/d) (View Cefuroxime Review and Cefuroxime Label ), STESOLID (10 Mg, Each Evening) (View Stesolid Review and Stesolid Label ), MORFIN (20 Mg, Each Evening) (View Morfin Review and Morfin Label ). Patient was hospitalized.

6471961-4 | Hypertension
on Apr 14, 2008 Female patient from GREECE , 68 years of age, was diagnosed with osteoporosis (What is osteoporosis?), hypercholesterolaemia and was treated with Teriparatide (View Usage). After Teriparatide was administered, patient had the following side effects: hypertension. Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with CALCIUM (View Calcium Review and Calcium Label ), CALCIORAL (View Calcioral Review and Calcioral Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ).

6471795-0 | Bone Scan Abnormal
Patient was taking Teriparatide (View Usage). Patient experienced the following unwanted or unexpected effects: bone scan abnormal on Feb 20, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 144.0 lb, was diagnosed with osteoporosis (What is osteoporosis?) and. Teriparatide dosage: 20 Ug, Unk. During the same period patient was treated with CALCIUM (View Calcium Review and Calcium Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

6471505-7 | Dysphagia, Hypersensitivity, Nausea
Adverse event was reported on May 22, 2008 by a Female patient taking Teriparatide (View Usage) (Dosage: 20 Ug, Daily (1/d)) was diagnosed with osteoporosis (What is osteoporosis?) and. Location: GREECE , 69 years of age, weighting 141.1 lb, Patient had the following side effects: dysphagia, hypersensitivity, nausea (What is nausea?). During the same period patient was treated with MEGA CALCIUM (1 G, Daily (1/d)) (View Mega Calcium Review and Mega Calcium Label ).

6470905-9 | Leiomyosarcoma Metastatic, Uterine Leiomyoma
on Sep 23, 2008 Female patient from UNITED STATES , weighting 141.0 lb, was diagnosed with osteoporosis (What is osteoporosis?), hypothyroidism, hypertension, prophylaxis, osteoarthritis (What is osteoarthritis?), temporal arteritis, gastrooesophageal reflux disease and was treated with Teriparatide (View Usage). After Teriparatide was administered, patient had the following side effects: leiomyosarcoma metastatic, uterine leiomyoma. Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), CITRACAL (View Citracal Review and Citracal Label ), MONOPRIL (View Monopril Review and Monopril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ALEVE (View Aleve Review and Aleve Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ZANTAC (View Zantac Review and Zantac Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6469754-7 | Chronic Lymphocytic Leukaemia, Lymphoma, Spinal Compression Fracture
on Jan 12, 2009 Female patient from SWEDEN , weighting 135.1 lb, was diagnosed with osteoporosis postmenopausal and was treated with Teriparatide (View Usage). Patient experienced the following unwanted or unexpected effects: chronic lymphocytic leukaemia, lymphoma (What is lymphoma?), spinal compression fracture. Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with TROMBYL (75 Mg, Each Morning) (View Trombyl Review and Trombyl Label ), PLENDIL (7.5 Mg, Each Morning) (View Plendil Review and Plendil Label ), SALURES (5 Mg, Each Morning) (View Salures Review and Salures Label ), KALCIPOS D (Unk Unk, Each Morning) (View Kalcipos-d Review and Kalcipos-d Label ), STILNOCT (10 Mg, Each Evening) (View Stilnoct Review and Stilnoct Label ), KININ (100 Mg, Each Evening) (View Kinin Review and Kinin Label ), SIFROL (0.09 Mg, Each Evening) (View Sifrol Review and Sifrol Label ), LEVOTHYROXINE SODIUM (50 Ug, 5/w) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized and became disabled.

6469186-1 | Calculus Ureteric
Patient was taking Teriparatide (View Usage). Patient had the following side effects: calculus ureteric on Nov 09, 2007 from AUSTRALIA Additional patient health information: Female patient , 82 years of age, was diagnosed with osteoporosis (What is osteoporosis?), depression (What is depression?), hypertension, dyspepsia and. Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with LOVAN (20 Mg, Unk) (View Lovan Review and Lovan Label ), ATACAND (25.5 Mg, Unk) (View Atacand Review and Atacand Label ), ZANTAC (150 Mg, Unk) (View Zantac Review and Zantac Label ). Patient was hospitalized.

6468780-1 | Presyncope
Adverse event was reported on Aug 21, 2008 by a Female patient taking Teriparatide (View Usage) (Dosage: 20 Ug, Daily (1/d)) was diagnosed with osteoporosis (What is osteoporosis?), scleroderma (What is scleroderma?), gastrooesophageal reflux disease, pain (What is pain?), musculoskeletal discomfort, constipation (What is constipation?) and. Location: UNITED STATES , weighting 129.0 lb, After Teriparatide was administered, patient had the following side effects: presyncope. During the same period patient was treated with CYMBALTA (Unk, Unk) (View Cymbalta Review and Cymbalta Label ), IMURAN (Unk, Unk) (View Imuran Review and Imuran Label ), PREDNISONE (Unk, Unk) (View Prednisone Review and Prednisone Label ), PREMPRO (Unk, Unk) (View Prempro Review and Prempro Label ), PROTONIX (Unk, Unk) (View Protonix Review and Protonix Label ), VICODIN (Unk, Unk) (View Vicodin Review and Vicodin Label ), FLEXERIL (Unk, Unk) (View Flexeril Review and Flexeril Label ), COLACE (Unk, Unk) (View Colace Review and Colace Label ). Patient was hospitalized.

6451714-3 | Abdominal Discomfort, Abdominal Infection, Dyspnoea, Pain In Extremity
on Nov 23, 2009 Male patient from INDIA , weighting 83.78 lb, was diagnosed with spinal fracture, chronic obstructive pulmonary disease, osteoporosis (What is osteoporosis?) and was treated with Teriparatide (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, abdominal infection, dyspnoea, pain in extremity. Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with TIOTROPIUM BROMIDE (2 D/f, Daily (1/d)) (View Tiotropium Bromide Review and Tiotropium Bromide Label ), FORMOTEROL FUMARATE (2 D/f, Daily (1/d)) (View Formoterol Fumarate Review and Formoterol Fumarate Label ), FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ), ALPHA D3 (View Alpha D3 Review and Alpha D3 Label ), SHELCAL (500 Mg, Daily (1/d)) (View Shelcal Review and Shelcal Label ), CALCITONIN (1 D/f, Each Nostril 2/d) (View Calcitonin Review and Calcitonin Label ), PANTOPRAZOLE (40 Mg, 2/d) (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

6424894-3 | Operative Haemorrhage
on Oct 21, 2009 Female patient from LEBANON , 62 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Teriparatide (View Usage). Patient had the following side effects: operative haemorrhage. Teriparatide dosage: Unk Unk, Daily (1/d).

6387820-1 | Hypersensitivity, Rash
Patient was taking Teriparatide (View Usage). After Teriparatide was administered, patient had the following side effects: hypersensitivity, rash (What is rash?) on Sep 23, 2009 from LEBANON Additional patient health information: Female patient , 65 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and. Teriparatide dosage: .

6367787-2 | Surgery
Adverse event was reported on Sep 08, 2009 by a Female patient taking Teriparatide (View Usage) (Dosage: Unk Unk, Daily (1/d)) was diagnosed with osteoporosis (What is osteoporosis?) and. Location: LEBANON , 62 years of age, Patient experienced the following unwanted or unexpected effects: surgery (What is surgery?).

6316244-8 |
on Aug 13, 2009 Female patient from DENMARK , weighting 102.7 lb, was diagnosed with osteoporosis (What is osteoporosis?), back pain (What is back pain?), hypertension and was treated with Teriparatide (View Usage). . Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with DOLOL (50 Mg, As Needed) (View Dolol Review and Dolol Label ), CORODIL (View Corodil Review and Corodil Label ), CALCIUM (View Calcium Review and Calcium Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

6244765-5 | Skin Cancer
on Jun 15, 2009 Female patient from JAPAN , 65 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Teriparatide (View Usage). After Teriparatide was administered, patient had the following side effects: skin cancer (What is skin cancer?). Teriparatide dosage: 20 Ug, Daily (1/d).

6220945-X | Breast Cancer Recurrent
Patient was taking Teriparatide (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer recurrent on May 29, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 143.0 lb, was diagnosed with osteoporosis (What is osteoporosis?), prophylaxis, heart rate increased, arthropathy, hypothyroidism and. Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (25 Mg, Unk) (View Atenolol Review and Atenolol Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), GLUCOSAMINE (1000 Ug, Unk) (View Glucosamine Review and Glucosamine Label ), LEVOXYL (50 Ug, Unk) (View Levoxyl Review and Levoxyl Label ), FOSAMAX (70 Mg, Unk) (View Fosamax Review and Fosamax Label ), ASCORBIC ACID (1000 Mg, Unk) (View Ascorbic Acid Review and Ascorbic Acid Label ).

6218027-6 | Injection Site Pain, Pain In Extremity
Adverse event was reported on May 24, 2009 by a Female patient taking Teriparatide (View Usage) (Dosage: 20 Ug, Daily (1/d)) was diagnosed with osteoporosis postmenopausal and. Location: EGYPT , 65 years of age, Patient had the following side effects: injection site pain, pain in extremity.

6190146-2 | Injection Site Pain, Pain In Extremity
on May 04, 2009 Female patient from EGYPT , 65 years of age, was diagnosed with osteoporosis postmenopausal and was treated with Teriparatide (View Usage). After Teriparatide was administered, patient had the following side effects: injection site pain, pain in extremity. Teriparatide dosage: 20 Ug, Daily (1/d).

6135391-7 | Fall, Hepatic Steatosis, Osteoporotic Fracture, Rib Fracture
on Mar 16, 2009 Female patient from NETHERLANDS , weighting 136.7 lb, was treated with Teriparatide (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), hepatic steatosis, osteoporotic fracture, rib fracture. Teriparatide dosage: . Patient was hospitalized.

6133362-8 | Bone Density Decreased, Diarrhoea, Neoplasm Malignant, Tooth Disorder, Weight Decreased
Patient was taking Teriparatide (View Usage). Patient had the following side effects: bone density decreased, diarrhoea, neoplasm malignant, tooth disorder (What is tooth disorder?), weight decreased on Mar 16, 2009 from UNITED STATES Additional patient health information: Female patient , 76 years of age, weighting 89.98 lb, . Teriparatide dosage: . During the same period patient was treated with EVISTA (View Evista Review and Evista Label ), ACTONEL (View Actonel Review and Actonel Label ), SYNTHROID (0.088 Mg, Unk) (View Synthroid Review and Synthroid Label ), BENICAR (20 Mg, Unk) (View Benicar Review and Benicar Label ), CALCIUM W/VITAMIN D /00188401/ (View Calcium W/vitamin D /00188401/ Review and Calcium W/vitamin D /00188401/ Label ), CENTRUM SILVER (View Centrum Silver Review and Centrum Silver Label ).

6129272-2 | Pain In Extremity
Adverse event was reported on Mar 16, 2009 by a Male patient taking Teriparatide (View Usage) (Dosage: 20 U, Daily (1/d)) was diagnosed with osteoporotic fracture and. Location: INDIA , weighting 79.37 lb, After Teriparatide was administered, patient had the following side effects: pain in extremity. Patient was hospitalized.

6112559-7 | Pain In Extremity
on Feb 27, 2009 Male patient from INDIA , weighting 79.37 lb, was diagnosed with osteoporotic fracture and was treated with Teriparatide (View Usage). Patient experienced the following unwanted or unexpected effects: pain in extremity. Teriparatide dosage: 20 U, Daily (1/d). Patient was hospitalized.

6108434-4 | Atrial Fibrillation, Cardiac Failure Congestive, Chronic Obstructive Pulmonary Disease, Myocardial Infarction
on Feb 25, 2009 Female patient from UNITED STATES , weighting 100.3 lb, was diagnosed with osteoporosis (What is osteoporosis?), rheumatoid arthritis (What is rheumatoid arthritis?), blood calcium, vitamin supplementation and was treated with Teriparatide (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cardiac failure congestive, chronic obstructive pulmonary disease, myocardial infarction. Teriparatide dosage: 20 Ug, Unk. During the same period patient was treated with ENBREL (View Enbrel Review and Enbrel Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), VICODIN (View Vicodin Review and Vicodin Label ), NAPROSYN (View Naprosyn Review and Naprosyn Label ), CALCIUM (View Calcium Review and Calcium Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

6105754-4 | Dizziness, Fatigue, Feeling Abnormal, Gastrointestinal Necrosis, Intestinal Ischaemia, Postoperative Adhesion, Sepsis
Patient was taking Teriparatide (View Usage). After Teriparatide was administered, patient had the following side effects: dizziness (What is dizziness?), fatigue, feeling abnormal, gastrointestinal necrosis, intestinal ischaemia, postoperative adhesion, sepsis (What is sepsis?) on Feb 23, 2009 from UNITED KINGDOM Additional patient health information: Female patient , weighting 99.65 lb, was diagnosed with osteoporosis (What is osteoporosis?), rheumatoid arthritis (What is rheumatoid arthritis?), cardiac failure and. Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ADCAL D3 (View Adcal-d3 Review and Adcal-d3 Label ), ATENOLOL (View Atenolol Review and Atenolol Label ).

6104316-2 | Amnesia, Dizziness, Eructation, Hallucination
Adverse event was reported on Feb 23, 2009 by a Female patient taking Teriparatide (View Usage) (Dosage: 20 Ug, Daily (1/d)) was diagnosed with osteoporosis postmenopausal and. Location: EGYPT , 85 years of age, Patient experienced the following unwanted or unexpected effects: amnesia, dizziness (What is dizziness?), eructation, hallucination.

6093192-2 | Atrial Fibrillation, Cardiac Failure Congestive, Chronic Obstructive Pulmonary Disease, Myocardial Infarction
on Feb 13, 2009 Female patient from UNITED STATES , weighting 100.3 lb, was diagnosed with osteoporosis (What is osteoporosis?), rheumatoid arthritis (What is rheumatoid arthritis?), blood calcium, vitamin supplementation and was treated with Teriparatide (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cardiac failure congestive, chronic obstructive pulmonary disease, myocardial infarction. Teriparatide dosage: 20 Ug, Unk. During the same period patient was treated with ENBREL (View Enbrel Review and Enbrel Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), VICODIN (View Vicodin Review and Vicodin Label ), NAPROSYN (View Naprosyn Review and Naprosyn Label ), CALCIUM (View Calcium Review and Calcium Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

6083880-6 | Amnesia, Dizziness, Eructation, Hallucination
on Feb 08, 2009 Female patient from EGYPT , 85 years of age, was diagnosed with osteoporosis postmenopausal and was treated with Teriparatide (View Usage). After Teriparatide was administered, patient had the following side effects: amnesia, dizziness (What is dizziness?), eructation, hallucination. Teriparatide dosage: 20 Ug, Daily (1/d).

6047517-4 | Breast Cancer Recurrent
Patient was taking Teriparatide (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer recurrent on Jan 16, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 143.0 lb, was diagnosed with osteoporosis (What is osteoporosis?), prophylaxis, heart rate increased, arthropathy, hypothyroidism and. Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (25 Mg, Unk) (View Atenolol Review and Atenolol Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), GLUCOSAMINE (1000 Ug, Unk) (View Glucosamine Review and Glucosamine Label ), LEVOXYL (50 Ug, Unk) (View Levoxyl Review and Levoxyl Label ), FOSAMAX (70 Mg, Unk) (View Fosamax Review and Fosamax Label ), ASCORBIC ACID (1000 Mg, Unk) (View Ascorbic Acid Review and Ascorbic Acid Label ).

6047034-1 | Chronic Lymphocytic Leukaemia, Lymphoma, Spinal Compression Fracture
Adverse event was reported on Jan 12, 2009 by a Female patient taking Teriparatide (View Usage) (Dosage: 20 Ug, Daily (1/d)) was diagnosed with osteoporosis postmenopausal and. Location: SWEDEN , weighting 135.1 lb, Patient had the following side effects: chronic lymphocytic leukaemia, lymphoma (What is lymphoma?), spinal compression fracture. During the same period patient was treated with TROMBYL (75 Mg, Each Morning) (View Trombyl Review and Trombyl Label ), PLENDIL (7.5 Mg, Each Morning) (View Plendil Review and Plendil Label ), SALURES (5 Mg, Each Morning) (View Salures Review and Salures Label ), KALCIPOS D (Unk Unk, Each Morning) (View Kalcipos-d Review and Kalcipos-d Label ), ZOLPIDEM TARTRATE (10 Mg, Each Evening) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), KININ (100 Mg, Each Evening) (View Kinin Review and Kinin Label ), SIFROL (0.09 Mg, Each Evening) (View Sifrol Review and Sifrol Label ), LEVOTHYROXINE SODIUM (50 Ug, 5/w) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized and became disabled.

6023330-9 | Dizziness, Fatigue, Feeling Abnormal, Intestinal Ischaemia, Postoperative Adhesion
on Dec 22, 2008 Female patient from UNITED KINGDOM , weighting 99.65 lb, was diagnosed with osteoporosis (What is osteoporosis?), rheumatoid arthritis (What is rheumatoid arthritis?), cardiac failure and was treated with Teriparatide (View Usage). After Teriparatide was administered, patient had the following side effects: dizziness (What is dizziness?), fatigue, feeling abnormal, intestinal ischaemia, postoperative adhesion. Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), TRAMADOL (View Tramadol Review and Tramadol Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ADCAL D3 (View Adcal-d3 Review and Adcal-d3 Label ), ATENOLOL (View Atenolol Review and Atenolol Label ).

5956283-X | Cerebral Haemorrhage, Deep Vein Thrombosis, Pulmonary Embolism
on Nov 13, 2008 Female patient from DENMARK , weighting 121.3 lb, was diagnosed with osteoporosis (What is osteoporosis?), pain (What is pain?), cystitis, convulsion and was treated with Teriparatide (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?). Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with PAMOL (1 G, Each Evening) (View Pamol Review and Pamol Label ), CEFUROXIME (1500 Mg, 3/d) (View Cefuroxime Review and Cefuroxime Label ), DIAZEPAM (10 Mg, Each Evening) (View Diazepam Review and Diazepam Label ), MORFIN (20 Mg, Each Evening) (View Morfin Review and Morfin Label ). Patient was hospitalized.

5940221-X | Goitre
Patient was taking Teriparatide (View Usage). Patient had the following side effects: goitre on Oct 22, 2008 from GREECE Additional patient health information: Female patient , 74 years of age, was diagnosed with osteoporosis (What is osteoporosis?), rheumatoid arthritis (What is rheumatoid arthritis?) and. Teriparatide dosage: 20 Ug, Daily (1/d). During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CORTISONE (View Cortisone Review and Cortisone Label ), CALCIUM (View Calcium Review and Calcium Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).